Long-term health impacts of COVID-19 among 242,712 adults in England.
Long-term health impacts of COVID-19 among 242,712 adults in England.
复制标题
DOI:
10.1038/s41467-023-41879-2
复制
发表时间:
2023-10-24
影响因子:
16.6
通讯作者:
Elliott, Paul
中科院分区:
文献类型:
--
作者:
Atchison, Christina J.;Davies, Bethan;Cooper, Emily;Lound, Adam;Whitaker, Matthew;Hampshire, Adam;Azor, Adriana;Donnelly, Christl A.;Chadeau-Hyam, Marc;Cooke, Graham S.;Ward, Helen;Elliott, Paul
The COVID-19 pandemic is having a lasting impact on health and well-being. We compare current self-reported health, quality of life and symptom profiles for people with ongoing symptoms following COVID-19 to those who have never tested positive for SARS-CoV-2 infection and those who have recovered from COVID-19. Overall, 276,840/800,000 (34·6%) of invited participants took part. Mental health and health-related quality of life were worse among participants with ongoing persistent symptoms post-COVID compared with those who had never had COVID-19 or had recovered. In this study, median duration of COVID-related symptoms (N = 130,251) was 1·3 weeks (inter-quartile range 6 days to 2 weeks), with 7·5% and 5·2% reporting ongoing symptoms ≥12 weeks and ≥52 weeks respectively. Female sex, ≥1 comorbidity and being infected when Wild-type variant was dominant were associated with higher probability of symptoms lasting ≥12 weeks and longer recovery time in those with persistent symptoms. Although COVID-19 is usually of short duration, some adults experience persistent and burdensome illness. The duration of symptomatic COVID-19 and its impacts on health and quality of life are not well understood. In this study, the authors report results from a survey of ~275,000 adults in England and find that persistent COVID-19 is relatively rare but is associated with poorer mental health and health-related quality of life.
登录
查看更多内容
DOI:
10.1126/science.abn8347
发表时间:
2022-03-25
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Elliott P;Bodinier B;Eales O;Wang H;Haw D;Elliott J;Whitaker M;Jonnerby J;Tang D;Walters CE;Atchison C;Diggle PJ;Page AJ;Trotter AJ;Ashby D;Barclay W;Taylor G;Ward H;Darzi A;Cooke GS;Chadeau-Hyam M;Donnelly CA
通讯作者:
Donnelly CA
影响因子:
4.6
作者:
Lopez-Leon S;Wegman-Ostrosky T;Perelman C;Sepulveda R;Rebolledo PA;Cuapio A;Villapol S
通讯作者:
Villapol S
DOI:
10.1136/bmjmed-2022-000385
发表时间:
2023
期刊:
BMJ medicine
影响因子:
--
作者:
Byambasuren, Oyungerel;Stehlik, Paulina;Clark, Justin;Alcorn, Kylie;Glasziou, Paul
通讯作者:
Glasziou, Paul
DOI:
10.1016/s2213-2600(21)00383-0
发表时间:
2021-11
期刊:
The Lancet. Respiratory medicine
影响因子:
--
作者:
Evans RA;McAuley H;Harrison EM;Shikotra A;Singapuri A;Sereno M;Elneima O;Docherty AB;Lone NI;Leavy OC;Daines L;Baillie JK;Brown JS;Chalder T;De Soyza A;Diar Bakerly N;Easom N;Geddes JR;Greening NJ;Hart N;Heaney LG;Heller S;Howard L;Hurst JR;Jacob J;Jenkins RG;Jolley C;Kerr S;Kon OM;Lewis K;Lord JM;McCann GP;Neubauer S;Openshaw PJM;Parekh D;Pfeffer P;Rahman NM;Raman B;Richardson M;Rowland M;Semple MG;Shah AM;Singh SJ;Sheikh A;Thomas D;Toshner M;Chalmers JD;Ho LP;Horsley A;Marks M;Poinasamy K;Wain LV;Brightling CE;PHOSP-COVID Collaborative Group
通讯作者:
PHOSP-COVID Collaborative Group
影响因子:
3.8
作者:
Johnson, Sverre Urnes;Ulvenes, Pal Gunnar;Hoffart, Asle
通讯作者:
Hoffart, Asle